Serum Institute Of India To Acquire 20% Stake In IntegriMedical

  

IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises a high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, Serum Institute of India (SII) said in a statement.

 

Vaccines manufacturer Serum Institute of India (SII) on Friday said it is acquiring 20 per cent stake in IntegriMedical, to advance needle-free injection system technology.

 

SII To Acquire 20% in IntegriMedical

 

IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, Serum Institute of India (SII) said in a statement.

 

The company, however, did not disclose the financial details of the transaction.

 

Read more@ https://www.freepressjournal.in/business/serum-institute-of-india-to-acquire-20-stake-in-integrimedical

Comments

Popular posts from this blog

Intramuscular Injections

Intramuscular Injections: The Future of Pain-Free Vaccinations

Subcutaneous Injections